Le, X., Guo, X., Sun, J., Liu, L., Shen, Y., Wang, J., . . . Chen, J. (2022). Pharmacokinetic features of dolutegravir with rifampicin and rifabutin among patients coinfected with human immunodeficiency virus and tuberculosis/mycobacterium avium complex. Elsevier.
Style de citation Chicago (17e éd.)Le, Xiaoqin, et al. Pharmacokinetic Features of Dolutegravir with Rifampicin and Rifabutin Among Patients Coinfected with Human Immunodeficiency Virus and Tuberculosis/mycobacterium Avium Complex. Elsevier, 2022.
Style de citation MLA (9e éd.)Le, Xiaoqin, et al. Pharmacokinetic Features of Dolutegravir with Rifampicin and Rifabutin Among Patients Coinfected with Human Immunodeficiency Virus and Tuberculosis/mycobacterium Avium Complex. Elsevier, 2022.
Attention : ces citations peuvent ne pas être correctes à 100%.